Cargando…
Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations
BACKGROUND: Molecular characterization has the potential to advance the management of pediatric cancer and high-risk hematologic disease. The clinical integration of genome sequencing into standard clinical practice has been limited and the potential utility of genome sequencing to identify clinical...
Autores principales: | Oberg, Jennifer A., Glade Bender, Julia L., Sulis, Maria Luisa, Pendrick, Danielle, Sireci, Anthony N., Hsiao, Susan J., Turk, Andrew T., Dela Cruz, Filemon S., Hibshoosh, Hanina, Remotti, Helen, Zylber, Rebecca J., Pang, Jiuhong, Diolaiti, Daniel, Koval, Carrie, Andrews, Stuart J., Garvin, James H., Yamashiro, Darrell J., Chung, Wendy K., Emerson, Stephen G., Nagy, Peter L., Mansukhani, Mahesh M., Kung, Andrew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180407/ https://www.ncbi.nlm.nih.gov/pubmed/28007021 http://dx.doi.org/10.1186/s13073-016-0389-6 |
Ejemplares similares
-
Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience
por: Marks, Lianna J., et al.
Publicado: (2017) -
Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: a case for sequencing the germline
por: Pendrick, Danielle M., et al.
Publicado: (2019) -
A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma
por: Hsiao, Susan J., et al.
Publicado: (2017) -
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma
por: Dela Cruz, Filemon S., et al.
Publicado: (2016) -
Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma
por: Fazlollahi, Ladan, et al.
Publicado: (2019)